Guerbet Balans Gezondheid

Financiële gezondheid criteriumcontroles 4/6

Guerbet heeft een totaal eigen vermogen van €387.6M en een totale schuld van €381.1M, wat de schuld-eigenvermogensverhouding op 98.3% brengt. De totale activa en totale passiva bedragen respectievelijk €1.0B en €654.4M. De EBIT Guerbet is €59.1M waardoor de rentedekking 3.7 is. Het heeft contanten en kortetermijnbeleggingen van €39.0M.

Belangrijke informatie

98.3%

Verhouding schuld/eigen vermogen

€381.06m

Schuld

Rente dekkingsratio	3.7x
Contant	€39.05m
Aandelen	€387.59m
Totaal verplichtingen	€654.37m
Totaal activa	€1.04b

Recente financiële gezondheidsupdates

Recent updates

Guerbet SA (EPA:GBT) Might Not Be As Mispriced As It Looks After Plunging 29%

Nov 16

Is Guerbet (EPA:GBT) Using Too Much Debt?

Apr 27

Further Upside For Guerbet SA (EPA:GBT) Shares Could Introduce Price Risks After 48% Bounce

Feb 29

Returns On Capital At Guerbet (EPA:GBT) Paint A Concerning Picture

Feb 11

Guerbet SA (EPA:GBT) Screens Well But There Might Be A Catch

Jan 15

The Returns On Capital At Guerbet (EPA:GBT) Don't Inspire Confidence

Jul 22

Guerbet SA's (EPA:GBT) Intrinsic Value Is Potentially 92% Above Its Share Price

Jul 27

Analysts Have Been Trimming Their Guerbet SA (EPA:GBT) Price Target After Its Latest Report

Mar 28

Is Guerbet (EPA:GBT) A Risky Investment?

Oct 25

The Returns On Capital At Guerbet (EPA:GBT) Don't Inspire Confidence

Sep 23

Is Now The Time To Look At Buying Guerbet SA (EPA:GBT)?

May 27

We Think Guerbet (EPA:GBT) Is Taking Some Risk With Its Debt

May 04

Is Guerbet SA (EPA:GBT) A Good Fit For Your Dividend Portfolio?

Apr 05

Guerbet SA's (EPA:GBT) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Mar 19

What Type Of Shareholders Make Up Guerbet SA's (EPA:GBT) Share Registry?

Mar 01

When Should You Buy Guerbet SA (EPA:GBT)?

Feb 10

How Much Did Guerbet's(EPA:GBT) Shareholders Earn From Share Price Movements Over The Last Three Years?

Jan 28

Guerbet SA (EPA:GBT) Shares Could Be 25% Above Their Intrinsic Value Estimate

Jan 13

Would Guerbet SA (EPA:GBT) Be Valuable To Income Investors?

Dec 23

We Think Guerbet's (EPA:GBT) Statutory Profit Might Understate Its Earnings Potential

Dec 11

Do Its Financials Have Any Role To Play In Driving Guerbet SA's (EPA:GBT) Stock Up Recently?

Nov 27

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( €604.3M ) GBT } overtreffen de korte termijn passiva ( €240.0M ).

Langlopende schulden: De kortetermijnactiva GBT ( €604.3M ) overtreffen de langetermijnschulden ( €414.4M ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 88.2% ) GBT wordt als hoog beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van GBT is de afgelopen 5 jaar gedaald van 113% naar 98.3%.

Schuldendekking: De schuld van GBT wordt niet goed gedekt door de operationele kasstroom ( 18.5% ).

Rentedekking: De rentebetalingen op de schuld van GBT worden goed gedekt door EBIT ( 3.7 x dekking).

Guerbet Balans Gezondheid

Financiële gezondheid criteriumcontroles 4/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Is Guerbet (EPA:GBT) Using Too Much Debt?

Is Guerbet (EPA:GBT) A Risky Investment?

We Think Guerbet (EPA:GBT) Is Taking Some Risk With Its Debt

Recent updates

Guerbet SA (EPA:GBT) Might Not Be As Mispriced As It Looks After Plunging 29%

Guerbet SA to Report First Half, 2025 Results on Sep 25, 2025

Guerbet SA to Report Fiscal Year 2024 Results on Mar 27, 2025

Investor sentiment deteriorates as stock falls 20%

New major risk - Financial position

Guerbet SA Announces Board Changes

Is Guerbet (EPA:GBT) Using Too Much Debt?

Guerbet SA Provides Earnings Guidance for the Year 2024

Dividend of €0.50 announced

Price target increased by 22% to €36.38

Further Upside For Guerbet SA (EPA:GBT) Shares Could Introduce Price Risks After 48% Bounce

New minor risk - Share price stability

Returns On Capital At Guerbet (EPA:GBT) Paint A Concerning Picture

Price target increased by 8.4% to €20.68

Guerbet SA (EPA:GBT) Screens Well But There Might Be A Catch

Guerbet SA, Annual General Meeting, May 24, 2024

First half 2023 earnings released: EPS: €0.16 (vs €0.26 in 1H 2022)

The Returns On Capital At Guerbet (EPA:GBT) Don't Inspire Confidence

Guerbet Announces Management Appointments

Applied Radiology and Guerbet Launch 'Elucirem (Gadopiclenol) Injection

Full year 2022 earnings released: €3.25 loss per share (vs €2.59 profit in FY 2021)

Price target decreased by 14% to €20.65

Consensus EPS estimates fall by 26%

Guerbet Releases First Production Batch of Elucirem (Gadopiclenol) Injection, a Novel New Macrocyclic GBCA for Use in Contrast-Enhanced Magnetic Resonance Imaging

Guerbet SA, Annual General Meeting, May 26, 2023

Price target decreased to €23.94

Consensus forecasts updated

Price target decreased to €26.82

First half 2022 earnings released: EPS: €0.26 (vs €1.86 in 1H 2021)

Price target decreased to €30.90

Consensus forecasts updated

Price target decreased to €32.80

Guerbet Announces U.S. Food and Drug Administration (FDA) Approval of Elucirem (Gadopiclenol)

Price target decreased to €31.55

Guerbet SA's (EPA:GBT) Intrinsic Value Is Potentially 92% Above Its Share Price

Guerbet SA Confirms Revenue Guidance for the Year of 2022

Price target decreased to €36.18

Upcoming dividend of €0.85 per share

Guerbet Sa Provides Revenue Guidance for 2022

Guerbet Announces Appointment of Charlotte Bamière, General Counsel, to the Executive Committee

Guerbet Recently Submitted New Drug Application to the U.S. Food and Drug Administration

Full year 2021 earnings: Revenues in line with analyst expectations

Analysts Have Been Trimming Their Guerbet SA (EPA:GBT) Price Target After Its Latest Report

Is Guerbet (EPA:GBT) A Risky Investment?

First half 2021 earnings released

Guerbet Provides Group Earnings Guidance for the Year 2021

The Returns On Capital At Guerbet (EPA:GBT) Don't Inspire Confidence

Price target increased to €33.75

Consensus forecasts updated

Upcoming dividend of €0.70 per share

Is Now The Time To Look At Buying Guerbet SA (EPA:GBT)?

We Think Guerbet (EPA:GBT) Is Taking Some Risk With Its Debt

Is Guerbet SA (EPA:GBT) A Good Fit For Your Dividend Portfolio?

Full year 2020 earnings released

Guerbet SA's (EPA:GBT) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

What Type Of Shareholders Make Up Guerbet SA's (EPA:GBT) Share Registry?

New 90-day low: €29.85

Analysts update estimates

Guerbet SA to Report Fiscal Year 2020 Results on Mar 24, 2021

When Should You Buy Guerbet SA (EPA:GBT)?

How Much Did Guerbet's(EPA:GBT) Shareholders Earn From Share Price Movements Over The Last Three Years?

Guerbet SA, Annual General Meeting, May 28, 2021

New 90-day high: €35.65

Guerbet SA (EPA:GBT) Shares Could Be 25% Above Their Intrinsic Value Estimate

Would Guerbet SA (EPA:GBT) Be Valuable To Income Investors?

New 90-day high: €33.10

We Think Guerbet's (EPA:GBT) Statutory Profit Might Understate Its Earnings Potential

Guerbet SA Receives Us Food and Drug Administration Approval for the Commercial Sale of the Optiray Imaging Bulk Package (IBP)

Do Its Financials Have Any Role To Play In Driving Guerbet SA's (EPA:GBT) Stock Up Recently?

New 90-day high: €30.00

Analysts lower EPS estimates to €1.64

Price target lowered to €31.00